Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development	$ 813	$ 2,279
General and administrative	2,712	3,710
Total operating expenses	3,525	5,989
Loss from operations	(3,525)	(5,989)
Other income (expense):
Interest income		2
Interest expense	(55)
Gain on debt extinguishment	54
Change in fair value of warrant liability	(54)	649
Foreign currency exchange loss, net	(125)	(226)
Other expense, net		(2)
Total other income (expense), net	(180)	423
Net loss	$ (3,705)	$ (5,566)
Net (loss) income per share - basic	$ 0	$ 0
Net (loss) income per share - diluted	$ 0	$ 0
Weighted-average number of ordinary shares used in computing net (loss) income per share- basic	54,588,283,841	13,453,147,979
Weighted-average number of ordinary shares used in computing net (loss) income per share - diluted	54,588,283,841	13,453,147,979
Comprehensive (loss) income:
Net loss	$ (3,705)	$ (5,566)
Other comprehensive income, net of tax:
Foreign currency translation adjustment	(35)	279
Total other comprehensive income, net of tax	(35)	279
Total comprehensive (loss) income	$ (3,740)	$ (5,287)